Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Yuji Hirata"'
Autor:
Hiroshi Kumanomidou, Kengo Kanai, Aiko Oka, Takenori Haruna, Yuji Hirata, Sei-ichiro Makihara, Takaya Higaki, Maki Akamatsu, Yoshitaka Okamoto, Shunya Ikeda, Mitsuhiro Okano
Publikováno v:
Allergology International, Vol 71, Iss 2, Pp 207-213 (2022)
Background: The total naso-ocular symptom score (TSS) is widely used as an endpoint to evaluate the severity of seasonal allergic rhinitis. However, it is not a generic preference-based measure. We sought to develop an algorithm for mapping between t
Externí odkaz:
https://doaj.org/article/0d6b2e35b9564e328e1b59f476873385
Autor:
Takenori Haruna, Shin Kariya, Tazuko Fujiwara, Atsushi Yuta, Takaya Higaki, Pengfei Zhao, Yukiko Ogawa, Kengo Kanai, Yuji Hirata, Aiko Oka, Kazunori Nishizaki, Mitsuhiro Okano
Publikováno v:
Allergology International, Vol 68, Iss 1, Pp 82-89 (2019)
Background: The development of methods to predict the clinical effectiveness of sublingual immunotherapy (SLIT) for allergic diseases is a crucial matter. We sought to determine whether whole saliva, which is the first body component that contacts al
Externí odkaz:
https://doaj.org/article/aaf125695c9d49ae994d27df6326e134
Autor:
Kengo Kanai, Mitsuhiro Okano, Tazuko Fujiwara, Shin Kariya, Takenori Haruna, Ryotaro Omichi, Sei-ichiro Makihara, Yuji Hirata, Kazunori Nishizaki
Publikováno v:
Allergology International, Vol 65, Iss 4, Pp 414-419 (2016)
Background: Vascular endothelial growth factor (VEGF) is known to be associated with the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). VEGF is produced by a variety of cells including fibroblasts. It was recently reported that pr
Externí odkaz:
https://doaj.org/article/c240272544cd424fa6b2d9c848d189ed
Autor:
Kengo Kanai M.D., Mitsuhiro Okano M.D., Takenori Haruna M.D., Takaya Higaki M.D., Ryotaro Omichi M.D., Sei-ichiro Makihara M.D., Munechika Tsumura M.D., Shin Kariya M.D., Yuji Hirata M.D., Kazunori Nishizaki M.D.
Publikováno v:
Allergy & Rhinology, Vol 8 (2017)
Objective In 2013, the Japanese Rhinologic Society proposed a simple classification for endoscopic sinus surgery (ESS). This classification consists of five procedures (type I, fenestration of the ostiomeatal complex, with uncinectomy and widening of
Externí odkaz:
https://doaj.org/article/f12ea7d4ffe74ab0a52a78599893963b
Publikováno v:
Practica Oto-Rhino-Laryngologica. 116:31-37
Autor:
Kengo Kanai, Takaya Higaki, Yuji Hirata, Rumi Fujiwara, Marie Yamamoto, Shin Kariya, Mitsuhiro Okano
Publikováno v:
Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology). 60:13-20
Autor:
Shin Kariya, Yuji Hirata, Ryotaro Omichi, Takaya Higaki, Tazuko Fujiwara, Aiko Oka, Mitsuhiro Okano, Kengo Kanai, Kazunori Nishizaki, Takenori Haruna, Sei ichiro Makihara
Publikováno v:
American Journal of Rhinology & Allergy. 35:44-51
Background Hyaluronan is one of the major extracellular matrixes in chronic rhinosinusitis (CRS) associated with tissue remodeling. Prostaglandin D2 (PGD2) is also associated with the pathogenesis of CRS. However, little is known about whether PGD2 r
Autor:
Yuji Hirata
Publikováno v:
Educational Studies in Japan. 13:135-151
Autor:
Takaya Higaki, Aiko Oka, Shin Kariya, Tazuko Fujiwara, Kazunori Nishizaki, Pengfei Zhao, Atsushi Yuta, Kengo Kanai, Takenori Haruna, Yukiko Ogawa, Yuji Hirata, Mitsuhiro Okano
Publikováno v:
Allergology International, Vol 68, Iss 1, Pp 82-89 (2019)
Background: The development of methods to predict the clinical effectiveness of sublingual immunotherapy (SLIT) for allergic diseases is a crucial matter. We sought to determine whether whole saliva, which is the first body component that contacts al
Autor:
Tatsuo Ichinohe, Keita Fujino, Masatoshi Nishizawa, Takahiko Miyama, Takehiko Morioka, Hisao Nagoshi, Teruhisa Fujii, Taro Edahiro, Yuji Hirata, Noriyasu Fukushima, Tatsuji Mino, Tetsumi Yoshida, Takakazu Kawase, Mitsunori Noma, Kayo Toishigawa
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
Optimal selection of pretransplant conditioning is crucially vital for improving survival and quality-of-life of patients who receive allogeneic hematopoietic cell transplantation (allo-HCT), particularly in those with high-risk diseases. In this stu